1. Bättre insatser vid missbruk och beroende SOU 2011:35. http://www.regeringen.se/sb/d/14017/a/167105
2. Levnadsvanor 2010. Statens folkhälsoinstitut (2010:13) http://www.fhi.se/Documents/Statistikuppfoljning/Folkhalsoenkaten/Resultat%202010/Levnadsvanor-l%C3%A4gesrapport- 2010.pdf
3. Fridell M, Hesse M, Jaeger MM, Kühlhorn E. Antisocial personality disorder as a predictor of criminal behaviour in a longitudinal study of a cohort of abusers of several classes of drugs: relation to type of substance and type of crime.. Addict Behav. 2008 Jun;33(6):799-811 http://www.ncbi.nlm.nih.gov/pubmed/18258375
4. Hemlöshet och utestängning från bostadsmarknaden 2011 – omfattning och karaktär, Socialstyrelsen 2011. http://www.socialstyrelsen.se/publikationer2011/2011-12-8
5. Håkansson A. Overdoses, suicidal behavior and clinical characteristics in heavy drug users. Studies in the Criminal Justice System. Clinical Alcohol Research Lund University 2009. http://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=1275688&fileO Id=1275689
6. Levin FR. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry. 2007; 68(suppl 11):9-14. http://www.ncbi.nlm.nih.gov/pubmed/18307376
7. Klassen L J. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations. Curr Drug Abuse Rev. 2012 Sep; 5(3):190-8. http://www.ncbi.nlm.nih.gov/pubmed/22571450
8. Murthy P, Chand P. Treatment of dual diagnosis disorders. Curr Opin Psychiatry. 2012 May;25(3):194-200. doi: 10.1097/YCO.0b013e328351a3e0. http://www.ncbi.nlm.nih.gov/pubmed/22395768
9. Paulus, M. P., Hozack, N. E., Zauscher, B. E., et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology. 2002 Jan;26(1):53-63. http://www.ncbi.nlm.nih.gov/pubmed/11751032
10. McCann UD, Kuwabara H, Kumar A, et al. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse. 2008 Feb;62(2):91- 100. http://www.ncbi.nlm.nih.gov/pubmed/17992686
11. Angrist, B.M. & Gershon, S. The phenomenology of experimentally induced amphetamine psychosis – preliminary observations. Biological Psychiatry. 1970 Apr;2(2):95-107. http://www.ncbi.nlm.nih.gov/pubmed/5459137
12. Espelin DE, Done AK (1968). Amphetamine poisoning, effectiveness of chlorpromazine. N Engl J Med 278:1361-5 http://www.ncbi.nlm.nih.gov/pubmed/5650165
13. Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, Föhr J, Tuomola P, Kuoppasalmi K, Kiviniemi V, Zwartau E. Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial; American Journal of Psychiatry (Feb 2012) /Am J Psychiatry. http://www.ncbi.nlm.nih.gov/pubmed/22764364
14. Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M. Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2010 Jan 20; http://www.ncbi.nlm.nih.gov/pubmed/20091613
15. 
    A) Huber, A.; Ling, W, Shoptaw, S, Gulati, V.; Brethen, P. Rawson, R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases 16(4):41-50, 1997. http://www.ncbi.nlm.nih.gov/pubmed/9328808
    
    B) Rawson, R., et al. An intensive outpatient approach for cocaine abuse: The Matrix model. Journal of Substance Abuse Treatment 12(2):117-127, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7623389

C) Rawson, R.A., et al. A comparison of contingency management and cognitivebehavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry 59(9):817-824, 2002. http://www.ncbi.nlm.nih.gov/pubmed/12215081